The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toripalimab combined with fluorouracil, leucovorin calcium, oxaliplatin and irinotecan (FOLFIRINOX) regimen or combined with oxaliplatin and tegafur (SOX) regimen in perioperative treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma (G/GEJ): An open-label, randomized, phase II study.
 
Rui Liu
No Relationships to Disclose
 
Zhi Ji
No Relationships to Disclose
 
Xia Wang
No Relationships to Disclose
 
Le Zhang
No Relationships to Disclose
 
Yuchong Yang
No Relationships to Disclose
 
Tao Ning
No Relationships to Disclose
 
Shaohua Ge
No Relationships to Disclose
 
Hongli Li
No Relationships to Disclose
 
Ming Bai
No Relationships to Disclose
 
Ting Deng
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose